nodes	percent_of_prediction	percent_of_DWPC	metapath
Prochlorperazine—CYP3A4—bone cancer	0.873	1	CbGaD
Prochlorperazine—Abnormal pigmentation—Epirubicin—bone cancer	0.00756	0.0624	CcSEcCtD
Prochlorperazine—Abnormal pigmentation—Doxorubicin—bone cancer	0.007	0.0578	CcSEcCtD
Prochlorperazine—Megacolon—Methotrexate—bone cancer	0.00464	0.0383	CcSEcCtD
Prochlorperazine—Venous thromboembolism—Epirubicin—bone cancer	0.00243	0.02	CcSEcCtD
Prochlorperazine—Venous thromboembolism—Doxorubicin—bone cancer	0.00224	0.0185	CcSEcCtD
Prochlorperazine—Pigmentation disorder—Epirubicin—bone cancer	0.00214	0.0176	CcSEcCtD
Prochlorperazine—Retinal disorder—Methotrexate—bone cancer	0.00213	0.0176	CcSEcCtD
Prochlorperazine—Pigmentation disorder—Doxorubicin—bone cancer	0.00198	0.0163	CcSEcCtD
Prochlorperazine—Infection—Carboplatin—bone cancer	0.00168	0.0138	CcSEcCtD
Prochlorperazine—Liver injury—Cisplatin—bone cancer	0.00165	0.0136	CcSEcCtD
Prochlorperazine—Sudden death—Methotrexate—bone cancer	0.00149	0.0123	CcSEcCtD
Prochlorperazine—Embolism venous—Epirubicin—bone cancer	0.00141	0.0117	CcSEcCtD
Prochlorperazine—Hepatocellular injury—Cisplatin—bone cancer	0.00139	0.0115	CcSEcCtD
Prochlorperazine—Body temperature increased—Carboplatin—bone cancer	0.00133	0.011	CcSEcCtD
Prochlorperazine—Embolism venous—Doxorubicin—bone cancer	0.00131	0.0108	CcSEcCtD
Prochlorperazine—Deep vein thrombosis—Methotrexate—bone cancer	0.00125	0.0103	CcSEcCtD
Prochlorperazine—Eruption—Methotrexate—bone cancer	0.00124	0.0102	CcSEcCtD
Prochlorperazine—Eruption—Epirubicin—bone cancer	0.00116	0.00957	CcSEcCtD
Prochlorperazine—Haemolytic anaemia—Cisplatin—bone cancer	0.00112	0.00921	CcSEcCtD
Prochlorperazine—Nasal congestion—Cisplatin—bone cancer	0.00111	0.00913	CcSEcCtD
Prochlorperazine—Cyanosis—Methotrexate—bone cancer	0.00108	0.00888	CcSEcCtD
Prochlorperazine—Eruption—Doxorubicin—bone cancer	0.00107	0.00885	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Cisplatin—bone cancer	0.00104	0.00859	CcSEcCtD
Prochlorperazine—Apnoea—Methotrexate—bone cancer	0.000898	0.00742	CcSEcCtD
Prochlorperazine—Glycosuria—Epirubicin—bone cancer	0.00088	0.00726	CcSEcCtD
Prochlorperazine—Blood disorder—Epirubicin—bone cancer	0.000853	0.00705	CcSEcCtD
Prochlorperazine—Liver injury—Epirubicin—bone cancer	0.000847	0.00699	CcSEcCtD
Prochlorperazine—Pancytopenia—Cisplatin—bone cancer	0.000827	0.00683	CcSEcCtD
Prochlorperazine—Clomipramine—GSTP1—bone cancer	0.000819	0.135	CrCbGaD
Prochlorperazine—Glycosuria—Doxorubicin—bone cancer	0.000814	0.00672	CcSEcCtD
Prochlorperazine—Jaundice cholestatic—Epirubicin—bone cancer	0.000811	0.0067	CcSEcCtD
Prochlorperazine—Amenorrhoea—Epirubicin—bone cancer	0.000811	0.0067	CcSEcCtD
Prochlorperazine—Blood disorder—Doxorubicin—bone cancer	0.00079	0.00652	CcSEcCtD
Prochlorperazine—Liver injury—Doxorubicin—bone cancer	0.000784	0.00647	CcSEcCtD
Prochlorperazine—Pulmonary embolism—Methotrexate—bone cancer	0.000762	0.00629	CcSEcCtD
Prochlorperazine—Dyskinesia—Epirubicin—bone cancer	0.000758	0.00626	CcSEcCtD
Prochlorperazine—Jaundice cholestatic—Doxorubicin—bone cancer	0.000751	0.0062	CcSEcCtD
Prochlorperazine—Amenorrhoea—Doxorubicin—bone cancer	0.000751	0.0062	CcSEcCtD
Prochlorperazine—Gait disturbance—Epirubicin—bone cancer	0.00073	0.00603	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Methotrexate—bone cancer	0.000715	0.0059	CcSEcCtD
Prochlorperazine—Pulmonary embolism—Epirubicin—bone cancer	0.000713	0.00588	CcSEcCtD
Prochlorperazine—Hepatocellular injury—Epirubicin—bone cancer	0.000713	0.00588	CcSEcCtD
Prochlorperazine—Dermatitis contact—Epirubicin—bone cancer	0.000704	0.00582	CcSEcCtD
Prochlorperazine—Dyskinesia—Doxorubicin—bone cancer	0.000702	0.00579	CcSEcCtD
Prochlorperazine—Coma—Methotrexate—bone cancer	0.000696	0.00575	CcSEcCtD
Prochlorperazine—Gynaecomastia—Methotrexate—bone cancer	0.000681	0.00563	CcSEcCtD
Prochlorperazine—Gait disturbance—Doxorubicin—bone cancer	0.000676	0.00558	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Epirubicin—bone cancer	0.000669	0.00552	CcSEcCtD
Prochlorperazine—Pulmonary embolism—Doxorubicin—bone cancer	0.00066	0.00544	CcSEcCtD
Prochlorperazine—Hepatocellular injury—Doxorubicin—bone cancer	0.00066	0.00544	CcSEcCtD
Prochlorperazine—Dermatitis contact—Doxorubicin—bone cancer	0.000652	0.00538	CcSEcCtD
Prochlorperazine—Coma—Epirubicin—bone cancer	0.000651	0.00538	CcSEcCtD
Prochlorperazine—Photosensitivity—Methotrexate—bone cancer	0.00063	0.0052	CcSEcCtD
Prochlorperazine—Arrhythmia—Cisplatin—bone cancer	0.000623	0.00514	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Doxorubicin—bone cancer	0.000619	0.00511	CcSEcCtD
Prochlorperazine—Erythema—Cisplatin—bone cancer	0.000607	0.00501	CcSEcCtD
Prochlorperazine—Coma—Doxorubicin—bone cancer	0.000603	0.00497	CcSEcCtD
Prochlorperazine—Photosensitivity—Epirubicin—bone cancer	0.000589	0.00486	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Methotrexate—bone cancer	0.000586	0.00484	CcSEcCtD
Prochlorperazine—Muscle spasms—Cisplatin—bone cancer	0.000583	0.00482	CcSEcCtD
Prochlorperazine—Eczema—Epirubicin—bone cancer	0.000576	0.00475	CcSEcCtD
Prochlorperazine—Vision blurred—Cisplatin—bone cancer	0.000572	0.00472	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Methotrexate—bone cancer	0.000571	0.00472	CcSEcCtD
Prochlorperazine—Tremor—Cisplatin—bone cancer	0.000568	0.00469	CcSEcCtD
Prochlorperazine—Increased appetite—Epirubicin—bone cancer	0.000551	0.00455	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Epirubicin—bone cancer	0.000548	0.00453	CcSEcCtD
Prochlorperazine—Alimemazine—CYP3A4—bone cancer	0.000547	0.0903	CrCbGaD
Prochlorperazine—Photosensitivity—Doxorubicin—bone cancer	0.000545	0.0045	CcSEcCtD
Prochlorperazine—Leukopenia—Cisplatin—bone cancer	0.000543	0.00448	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Epirubicin—bone cancer	0.000535	0.00441	CcSEcCtD
Prochlorperazine—Eczema—Doxorubicin—bone cancer	0.000533	0.0044	CcSEcCtD
Prochlorperazine—Hypoglycaemia—Epirubicin—bone cancer	0.00053	0.00438	CcSEcCtD
Prochlorperazine—Convulsion—Cisplatin—bone cancer	0.000526	0.00434	CcSEcCtD
Prochlorperazine—Increased appetite—Doxorubicin—bone cancer	0.00051	0.00421	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Doxorubicin—bone cancer	0.000507	0.00419	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Cisplatin—bone cancer	0.000495	0.00409	CcSEcCtD
Prochlorperazine—Oedema—Cisplatin—bone cancer	0.000495	0.00409	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Doxorubicin—bone cancer	0.000495	0.00408	CcSEcCtD
Prochlorperazine—Cardiac arrest—Epirubicin—bone cancer	0.000492	0.00406	CcSEcCtD
Prochlorperazine—Infection—Cisplatin—bone cancer	0.000492	0.00406	CcSEcCtD
Prochlorperazine—Hypoglycaemia—Doxorubicin—bone cancer	0.000491	0.00405	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Cisplatin—bone cancer	0.000485	0.004	CcSEcCtD
Prochlorperazine—Skin disorder—Cisplatin—bone cancer	0.000481	0.00397	CcSEcCtD
Prochlorperazine—Asthma—Methotrexate—bone cancer	0.000478	0.00394	CcSEcCtD
Prochlorperazine—Eosinophilia—Methotrexate—bone cancer	0.000473	0.00391	CcSEcCtD
Prochlorperazine—Mequitazine—CYP3A4—bone cancer	0.000471	0.0777	CrCbGaD
Prochlorperazine—Domperidone—CYP3A4—bone cancer	0.000465	0.0768	CrCbGaD
Prochlorperazine—Hypotension—Cisplatin—bone cancer	0.000463	0.00382	CcSEcCtD
Prochlorperazine—Cardiac arrest—Doxorubicin—bone cancer	0.000455	0.00376	CcSEcCtD
Prochlorperazine—Pancytopenia—Methotrexate—bone cancer	0.000454	0.00375	CcSEcCtD
Prochlorperazine—Dysphagia—Epirubicin—bone cancer	0.000447	0.00369	CcSEcCtD
Prochlorperazine—Asthma—Epirubicin—bone cancer	0.000447	0.00369	CcSEcCtD
Prochlorperazine—Influenza—Epirubicin—bone cancer	0.000447	0.00369	CcSEcCtD
Prochlorperazine—Eosinophilia—Epirubicin—bone cancer	0.000443	0.00366	CcSEcCtD
Prochlorperazine—Dyspnoea—Cisplatin—bone cancer	0.000441	0.00364	CcSEcCtD
Prochlorperazine—Erectile dysfunction—Methotrexate—bone cancer	0.00044	0.00363	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Methotrexate—bone cancer	0.000436	0.0036	CcSEcCtD
Prochlorperazine—Drowsiness—Methotrexate—bone cancer	0.000426	0.00352	CcSEcCtD
Prochlorperazine—Pancytopenia—Epirubicin—bone cancer	0.000425	0.00351	CcSEcCtD
Prochlorperazine—Dysphagia—Doxorubicin—bone cancer	0.000414	0.00342	CcSEcCtD
Prochlorperazine—Asthma—Doxorubicin—bone cancer	0.000414	0.00342	CcSEcCtD
Prochlorperazine—Influenza—Doxorubicin—bone cancer	0.000414	0.00342	CcSEcCtD
Prochlorperazine—Eosinophilia—Doxorubicin—bone cancer	0.00041	0.00338	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Epirubicin—bone cancer	0.000408	0.00337	CcSEcCtD
Prochlorperazine—Weight increased—Epirubicin—bone cancer	0.000407	0.00336	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Epirubicin—bone cancer	0.000403	0.00333	CcSEcCtD
Prochlorperazine—Drowsiness—Epirubicin—bone cancer	0.000399	0.00329	CcSEcCtD
Prochlorperazine—Agranulocytosis—Methotrexate—bone cancer	0.000398	0.00328	CcSEcCtD
Prochlorperazine—Pancytopenia—Doxorubicin—bone cancer	0.000393	0.00324	CcSEcCtD
Prochlorperazine—Body temperature increased—Cisplatin—bone cancer	0.000391	0.00323	CcSEcCtD
Prochlorperazine—Jaundice—Epirubicin—bone cancer	0.000389	0.00321	CcSEcCtD
Prochlorperazine—Nefazodone—CYP3A4—bone cancer	0.000386	0.0638	CrCbGaD
Prochlorperazine—Photosensitivity reaction—Doxorubicin—bone cancer	0.000378	0.00312	CcSEcCtD
Prochlorperazine—Weight increased—Doxorubicin—bone cancer	0.000377	0.00311	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Doxorubicin—bone cancer	0.000373	0.00308	CcSEcCtD
Prochlorperazine—Agranulocytosis—Epirubicin—bone cancer	0.000372	0.00307	CcSEcCtD
Prochlorperazine—Drowsiness—Doxorubicin—bone cancer	0.000369	0.00305	CcSEcCtD
Prochlorperazine—Hypersensitivity—Cisplatin—bone cancer	0.000365	0.00301	CcSEcCtD
Prochlorperazine—Erythema multiforme—Methotrexate—bone cancer	0.000362	0.00299	CcSEcCtD
Prochlorperazine—Jaundice—Doxorubicin—bone cancer	0.00036	0.00297	CcSEcCtD
Prochlorperazine—Aripiprazole—CYP3A4—bone cancer	0.000359	0.0593	CrCbGaD
Prochlorperazine—Trazodone—CYP3A4—bone cancer	0.000357	0.059	CrCbGaD
Prochlorperazine—Oedema peripheral—Epirubicin—bone cancer	0.000353	0.00291	CcSEcCtD
Prochlorperazine—Agranulocytosis—Doxorubicin—bone cancer	0.000344	0.00284	CcSEcCtD
Prochlorperazine—Erythema multiforme—Epirubicin—bone cancer	0.000338	0.00279	CcSEcCtD
Prochlorperazine—Pipotiazine—CYP3A4—bone cancer	0.000335	0.0553	CrCbGaD
Prochlorperazine—Clobazam—CYP3A4—bone cancer	0.000335	0.0553	CrCbGaD
Prochlorperazine—Erythema—Methotrexate—bone cancer	0.000333	0.00275	CcSEcCtD
Prochlorperazine—Oedema peripheral—Doxorubicin—bone cancer	0.000326	0.00269	CcSEcCtD
Prochlorperazine—Arrhythmia—Epirubicin—bone cancer	0.00032	0.00264	CcSEcCtD
Prochlorperazine—Vision blurred—Methotrexate—bone cancer	0.000314	0.00259	CcSEcCtD
Prochlorperazine—Erythema multiforme—Doxorubicin—bone cancer	0.000313	0.00259	CcSEcCtD
Prochlorperazine—Rash—Cisplatin—bone cancer	0.000312	0.00258	CcSEcCtD
Prochlorperazine—Dermatitis—Cisplatin—bone cancer	0.000312	0.00258	CcSEcCtD
Prochlorperazine—Erythema—Epirubicin—bone cancer	0.000312	0.00257	CcSEcCtD
Prochlorperazine—Nervousness—Epirubicin—bone cancer	0.000303	0.0025	CcSEcCtD
Prochlorperazine—Muscle spasms—Epirubicin—bone cancer	0.0003	0.00247	CcSEcCtD
Prochlorperazine—Leukopenia—Methotrexate—bone cancer	0.000298	0.00246	CcSEcCtD
Prochlorperazine—Arrhythmia—Doxorubicin—bone cancer	0.000296	0.00244	CcSEcCtD
Prochlorperazine—Vision blurred—Epirubicin—bone cancer	0.000294	0.00242	CcSEcCtD
Prochlorperazine—Cough—Methotrexate—bone cancer	0.000291	0.0024	CcSEcCtD
Prochlorperazine—Mianserin—CYP3A4—bone cancer	0.000289	0.0478	CrCbGaD
Prochlorperazine—Convulsion—Methotrexate—bone cancer	0.000288	0.00238	CcSEcCtD
Prochlorperazine—Erythema—Doxorubicin—bone cancer	0.000288	0.00238	CcSEcCtD
Prochlorperazine—Agitation—Epirubicin—bone cancer	0.000286	0.00236	CcSEcCtD
Prochlorperazine—Nervousness—Doxorubicin—bone cancer	0.00028	0.00231	CcSEcCtD
Prochlorperazine—Leukopenia—Epirubicin—bone cancer	0.000279	0.0023	CcSEcCtD
Prochlorperazine—Muscle spasms—Doxorubicin—bone cancer	0.000277	0.00229	CcSEcCtD
Prochlorperazine—Cough—Epirubicin—bone cancer	0.000272	0.00224	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Methotrexate—bone cancer	0.000272	0.00224	CcSEcCtD
Prochlorperazine—Vision blurred—Doxorubicin—bone cancer	0.000272	0.00224	CcSEcCtD
Prochlorperazine—Convulsion—Epirubicin—bone cancer	0.00027	0.00223	CcSEcCtD
Prochlorperazine—Infection—Methotrexate—bone cancer	0.00027	0.00223	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Methotrexate—bone cancer	0.000266	0.0022	CcSEcCtD
Prochlorperazine—Agitation—Doxorubicin—bone cancer	0.000265	0.00219	CcSEcCtD
Prochlorperazine—Clomipramine—CYP3A4—bone cancer	0.000265	0.0437	CrCbGaD
Prochlorperazine—Skin disorder—Methotrexate—bone cancer	0.000264	0.00218	CcSEcCtD
Prochlorperazine—Dry mouth—Epirubicin—bone cancer	0.000259	0.00214	CcSEcCtD
Prochlorperazine—Leukopenia—Doxorubicin—bone cancer	0.000258	0.00213	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Epirubicin—bone cancer	0.000254	0.0021	CcSEcCtD
Prochlorperazine—Oedema—Epirubicin—bone cancer	0.000254	0.0021	CcSEcCtD
Prochlorperazine—Hypotension—Methotrexate—bone cancer	0.000254	0.0021	CcSEcCtD
Prochlorperazine—Infection—Epirubicin—bone cancer	0.000253	0.00209	CcSEcCtD
Prochlorperazine—Cough—Doxorubicin—bone cancer	0.000252	0.00208	CcSEcCtD
Prochlorperazine—Convulsion—Doxorubicin—bone cancer	0.00025	0.00206	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Epirubicin—bone cancer	0.000249	0.00206	CcSEcCtD
Prochlorperazine—Skin disorder—Epirubicin—bone cancer	0.000247	0.00204	CcSEcCtD
Prochlorperazine—Insomnia—Methotrexate—bone cancer	0.000246	0.00203	CcSEcCtD
Prochlorperazine—Dyspnoea—Methotrexate—bone cancer	0.000242	0.002	CcSEcCtD
Prochlorperazine—Somnolence—Methotrexate—bone cancer	0.000242	0.00199	CcSEcCtD
Prochlorperazine—Dry mouth—Doxorubicin—bone cancer	0.00024	0.00198	CcSEcCtD
Prochlorperazine—Hypotension—Epirubicin—bone cancer	0.000238	0.00196	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Doxorubicin—bone cancer	0.000235	0.00194	CcSEcCtD
Prochlorperazine—Oedema—Doxorubicin—bone cancer	0.000235	0.00194	CcSEcCtD
Prochlorperazine—Infection—Doxorubicin—bone cancer	0.000234	0.00193	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Doxorubicin—bone cancer	0.00023	0.0019	CcSEcCtD
Prochlorperazine—Insomnia—Epirubicin—bone cancer	0.00023	0.0019	CcSEcCtD
Prochlorperazine—Perphenazine—CYP3A4—bone cancer	0.000229	0.0378	CrCbGaD
Prochlorperazine—Skin disorder—Doxorubicin—bone cancer	0.000229	0.00189	CcSEcCtD
Prochlorperazine—Dyspnoea—Epirubicin—bone cancer	0.000227	0.00187	CcSEcCtD
Prochlorperazine—Somnolence—Epirubicin—bone cancer	0.000226	0.00187	CcSEcCtD
Prochlorperazine—Quetiapine—CYP3A4—bone cancer	0.000224	0.037	CrCbGaD
Prochlorperazine—Hypotension—Doxorubicin—bone cancer	0.00022	0.00182	CcSEcCtD
Prochlorperazine—Constipation—Epirubicin—bone cancer	0.000217	0.0018	CcSEcCtD
Prochlorperazine—Urticaria—Methotrexate—bone cancer	0.000216	0.00178	CcSEcCtD
Prochlorperazine—Body temperature increased—Methotrexate—bone cancer	0.000215	0.00177	CcSEcCtD
Prochlorperazine—Desipramine—CYP3A4—bone cancer	0.000213	0.0352	CrCbGaD
Prochlorperazine—Insomnia—Doxorubicin—bone cancer	0.000213	0.00176	CcSEcCtD
Prochlorperazine—Dyspnoea—Doxorubicin—bone cancer	0.00021	0.00173	CcSEcCtD
Prochlorperazine—Somnolence—Doxorubicin—bone cancer	0.000209	0.00173	CcSEcCtD
Prochlorperazine—Promazine—CYP3A4—bone cancer	0.000206	0.0341	CrCbGaD
Prochlorperazine—Urticaria—Epirubicin—bone cancer	0.000202	0.00167	CcSEcCtD
Prochlorperazine—Constipation—Doxorubicin—bone cancer	0.000201	0.00166	CcSEcCtD
Prochlorperazine—Body temperature increased—Epirubicin—bone cancer	0.000201	0.00166	CcSEcCtD
Prochlorperazine—Hypersensitivity—Methotrexate—bone cancer	0.0002	0.00165	CcSEcCtD
Prochlorperazine—Clozapine—CYP3A4—bone cancer	0.000193	0.0319	CrCbGaD
Prochlorperazine—Pruritus—Methotrexate—bone cancer	0.000192	0.00159	CcSEcCtD
Prochlorperazine—Hypersensitivity—Epirubicin—bone cancer	0.000187	0.00155	CcSEcCtD
Prochlorperazine—Urticaria—Doxorubicin—bone cancer	0.000187	0.00154	CcSEcCtD
Prochlorperazine—Body temperature increased—Doxorubicin—bone cancer	0.000186	0.00154	CcSEcCtD
Prochlorperazine—Chlorpromazine—CYP3A4—bone cancer	0.000182	0.03	CrCbGaD
Prochlorperazine—Imipramine—CYP3A4—bone cancer	0.000181	0.0298	CrCbGaD
Prochlorperazine—Pruritus—Epirubicin—bone cancer	0.00018	0.00149	CcSEcCtD
Prochlorperazine—Dizziness—Methotrexate—bone cancer	0.00018	0.00148	CcSEcCtD
Prochlorperazine—Hypersensitivity—Doxorubicin—bone cancer	0.000173	0.00143	CcSEcCtD
Prochlorperazine—Rash—Methotrexate—bone cancer	0.000171	0.00141	CcSEcCtD
Prochlorperazine—Dermatitis—Methotrexate—bone cancer	0.000171	0.00141	CcSEcCtD
Prochlorperazine—Headache—Methotrexate—bone cancer	0.00017	0.00141	CcSEcCtD
Prochlorperazine—Dizziness—Epirubicin—bone cancer	0.000168	0.00139	CcSEcCtD
Prochlorperazine—Pruritus—Doxorubicin—bone cancer	0.000166	0.00137	CcSEcCtD
Prochlorperazine—Rash—Epirubicin—bone cancer	0.00016	0.00132	CcSEcCtD
Prochlorperazine—Dermatitis—Epirubicin—bone cancer	0.00016	0.00132	CcSEcCtD
Prochlorperazine—Headache—Epirubicin—bone cancer	0.000159	0.00132	CcSEcCtD
Prochlorperazine—Dizziness—Doxorubicin—bone cancer	0.000156	0.00128	CcSEcCtD
Prochlorperazine—Rash—Doxorubicin—bone cancer	0.000148	0.00122	CcSEcCtD
Prochlorperazine—Dermatitis—Doxorubicin—bone cancer	0.000148	0.00122	CcSEcCtD
Prochlorperazine—Headache—Doxorubicin—bone cancer	0.000147	0.00122	CcSEcCtD
